Related Experiment Video
Updated: Jul 24, 2026
07:12
Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging
Published on: August 17, 2022
Parathyroid carcinoma: a 22-year experience.
Naifa L Busaidy1, Camilo Jimenez, Mouhammed Amir Habra
1joint Baylor College of Medicine/The University of Texas M. D. Anderson Cancer Center Training Program in Endocrinology, Diabetes, and Metabolism, Houston, Texas, USA.
Head & Neck
|August 3, 2004
Summary
Parathyroid carcinoma is rare, but complete surgical excision and adjuvant radiotherapy can improve local control and patient survival. Multidisciplinary care is essential for managing this indolent cancer.
Area of Science:
- Endocrinology
- Oncology
- Surgical Oncology
Background:
- Parathyroid carcinoma is a rare endocrine malignancy.
- Optimal management strategies are not well-established due to its rarity.
- Treatment often relies on clinical experience and anecdotal evidence.
Purpose of the Study:
- To report the experience with parathyroid carcinoma at a major cancer center.
- To evaluate treatment outcomes and identify factors influencing patient survival.
- To contribute to the understanding of parathyroid carcinoma management.
Main Methods:
- Retrospective review of 27 patients diagnosed with parathyroid carcinoma from 1980 onwards.
- Verification of medical records and pathology specimens.
- Analysis of treatment modalities including surgery and adjuvant radiotherapy, and patient follow-up data.
Main Results:
- The mean age at diagnosis was 46.7 years, with all patients presenting with hypercalcemia.
- Complete surgical excision was the primary treatment for 18 patients; 9 underwent en bloc resection for advanced disease.
- Adjuvant radiotherapy was associated with a lower local relapse rate (1/6) compared to no radiotherapy (10/20). 5- and 10-year survival rates were 85% and 77%, respectively.
Conclusions:
- Parathyroid carcinoma can exhibit indolent behavior, with hypercalcemia being a major cause of morbidity and mortality.
- Adjuvant radiotherapy may enhance local tumor control and reduce recurrence.
- A multidisciplinary approach involving surgery, radiation therapy, and hypercalcemia management is crucial for optimizing outcomes.
